NCT02982811 (i-ACT) is a NA clinical trial of i-ACT in Central Nervous System Diseases, sponsored by PXL University College.

Who is sponsoring NCT02982811?

NCT02982811 is sponsored by PXL University College.

What drugs are being tested in NCT02982811?

Interventions in NCT02982811: i-ACT.

What condition does NCT02982811 study?

NCT02982811 studies Central Nervous System Diseases, Aged.

Is NCT02982811 still recruiting?

NCT02982811 is currently completed. Last updated 27 July 2020.

Last reviewed 2020-07-27 · How we verify

NCT02982811: i-ACT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intelligent Activity-based Client-centred Training

Completed NA Last updated 27 July 2020

What this trial tests

NA trial testing i-ACT in Central Nervous System Diseases in 47 participants. Completed in 26 June 2020.

Timeline

1 March 2017

Primary endpoint
31 May 2020

26 June 2020

Quick facts

Lead sponsor	PXL University College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	47
Start date	1 March 2017
Primary completion	31 May 2020
Estimated completion	26 June 2020
Sites	4 locations across Belgium

Drugs / interventions tested

i-ACT

Conditions studied

Central Nervous System Diseases — all drugs for Central Nervous System Diseases →
Aged — all drugs for Aged →

Sponsor

PXL University College

Who can join

18 and older, any sex, with Central Nervous System Diseases or Aged. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether additional therapy with i-ACT system is effective in the training of functional skills in persons with central neurological diseases (e.g. multiple sclerosis, stroke, spinal cord injury, etc.).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Progress and Optimization of Information Processing in Artificial Visual Prostheses.
Wang J, Wang J, Zhao R, Li P, et al · · 2022 · cited 4× · PMID 36081002 · DOI 10.3390/s22176544
Efficacy of a technology-based client-centred training system in neurological rehabilitation: a randomised controlled trial.
Knippenberg E, Timmermans A, Coolen J, Neven K, et al · · 2021 · cited 2× · PMID 34961531 · DOI 10.1186/s12984-021-00977-2

Verify or expand the search:

Other trials of i-ACT

Trials testing the same drug.

NCT04906681 — Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: · Phase 1, PHASE2 · unknown
NCT04489563 — Feasibility Study of i-ACT in Aged Persons · NA · completed

Other recruiting trials for Central Nervous System Diseases

Currently open trials in the same condition.

NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
NCT07324330 — Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06835634 — Progressive Advancements in Neurosurgery, Data and Analysis Database · active not recruiting
NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting

Other PXL University College trials

Trials by the same sponsor.

NCT07431996 — Back to Work: Perspective of the Employee (Original Language Dutch: Terug-naar-werk: Perspectief Van Werknemer) · not yet recruiting
NCT06094374 — Unveiling the Digital Phenotype of PA Behavior · unknown
NCT05650515 — A Technology-based Exercise Program for Older Adults · unknown
NCT05234151 — The Newborn Early Warning System · unknown
NCT04906681 — Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: · Phase 1, PHASE2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02982811 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PXL University College
Last refreshed: 27 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02982811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing